{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:43:21Z","timestamp":1773661401968,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4972,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/labinvest.2009.23","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T01:18:13Z","timestamp":1238462293000},"page":"614-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders"],"prefix":"10.1016","volume":"89","author":[{"given":"Isabelle","family":"Mercier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanos","family":"Pavlides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Minetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Flomenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G","family":"Pestell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe G","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sotgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P","family":"Lisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2009.23_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(01)00472-X","article-title":"Emerging themes in lipid rafts and caveolae","volume":"106","author":"Galbiati","year":"2001","journal-title":"Cell"},{"key":"10.1038\/labinvest.2009.23_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","article-title":"Caveolin, a protein component of caveolae membrane coats","volume":"68","author":"Rothberg","year":"1992","journal-title":"Cell"},{"key":"10.1038\/labinvest.2009.23_bib3","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1073\/pnas.92.22.10339","article-title":"VIP21\/caveolin is a cholesterol-binding protein","volume":"92","author":"Murata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib4","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1073\/pnas.92.20.9407","article-title":"Oligomeric structure of caveolin: implications for caveolae membrane organization","volume":"92","author":"Sargiacomo","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1091\/mbc.6.7.911","article-title":"VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivoin vitro","volume":"6","author":"Monier","year":"1995","journal-title":"Mol Biol Cell"},{"key":"10.1038\/labinvest.2009.23_bib6","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1073\/pnas.89.21.10517","article-title":"Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts","volume":"89","author":"Glenney","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib7","doi-asserted-by":"crossref","first-page":"28647","DOI":"10.1074\/jbc.271.45.28647","article-title":"Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolar biogenesis","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"issue":"Part 6","key":"10.1038\/labinvest.2009.23_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1242\/jcs.111.6.825","article-title":"Expression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cells","volume":"111","author":"Vogel","year":"1998","journal-title":"J Cell Sci"},{"key":"10.1038\/labinvest.2009.23_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.93.1.131","article-title":"Identification, sequence and expression of caveolin-2 defines a caveolin gene family","volume":"93","author":"Scherer","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib10","doi-asserted-by":"crossref","first-page":"29337","DOI":"10.1074\/jbc.272.46.29337","article-title":"Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo","volume":"272","author":"Scherer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib11","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1074\/jbc.271.4.2255","article-title":"Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle","volume":"271","author":"Tang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/pr.54.3.431","article-title":"Caveolae: from cell biology to animal physiology","volume":"54","author":"Razani","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1038\/labinvest.2009.23_bib13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1073\/pnas.92.5.1381","article-title":"Reduction of caveolin and caveolae in oncogenically transformed cells","volume":"92","author":"Koleske","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib14","doi-asserted-by":"crossref","first-page":"16374","DOI":"10.1074\/jbc.272.26.16374","article-title":"Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth","volume":"272","author":"Engelman","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.onc.1201661","article-title":"Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells","volume":"16","author":"Lee","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.2009.23_bib16","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1093\/emboj\/17.22.6633","article-title":"Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42\/44 MAP kinase cascade","volume":"17","author":"Galbiati","year":"1998","journal-title":"EMBO J"},{"key":"10.1038\/labinvest.2009.23_bib17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0002-9440(10)64412-4","article-title":"Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1(\u2212\/\u2212) null mice show mammary epithelial cell hyperplasia","volume":"161","author":"Lee","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib18","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1091\/mbc.02-05-0071","article-title":"Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2\/STAT5a signaling cascade","volume":"13","author":"Park","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1038\/labinvest.2009.23_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1091\/mbc.e02-08-0503","article-title":"Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice","volume":"14","author":"Williams","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1038\/labinvest.2009.23_bib20","doi-asserted-by":"crossref","first-page":"51630","DOI":"10.1074\/jbc.M409214200","article-title":"Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2\/9) secretion","volume":"279","author":"Williams","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib21","doi-asserted-by":"crossref","first-page":"24745","DOI":"10.1074\/jbc.M402064200","article-title":"Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a\/CAV-1 in mammary epithelial cell hyperplasia","volume":"279","author":"Williams","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib22","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0002-9440(10)64335-0","article-title":"Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation","volume":"162","author":"Capozza","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib23","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1074\/jbc.M501186200","article-title":"Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice","volume":"280","author":"Williams","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib24","first-page":"5719","article-title":"Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker","volume":"59","author":"Yang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2009.23_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0090-4295(01)01337-1","article-title":"Caveolin-1 expression is associated with high-grade bladder cancer","volume":"58","author":"Rajjayabun","year":"2001","journal-title":"Urology"},{"key":"10.1038\/labinvest.2009.23_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/292NHAYNWAVREJ37","article-title":"Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation","volume":"120","author":"Fong","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/labinvest.2009.23_bib27","first-page":"1873","article-title":"Elevated expression of caveolin is associated with prostate and breast cancer","volume":"4","author":"Yang","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2009.23_bib28","first-page":"3882","article-title":"Secreted caveolin-1 stimulates cell survival\/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer","volume":"61","author":"Tahir","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2009.23_bib29","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1074\/jbc.M005448200","article-title":"Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum","volume":"276","author":"Schlegel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4161\/cc.4.12.2199","article-title":"Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation","volume":"4","author":"Li","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1038\/labinvest.2009.23_bib31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2353\/ajpath.2006.060590","article-title":"Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells","volume":"169","author":"Williams","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib32","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4161\/cc.4.12.2198","article-title":"Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt\/beta-catenin signaling","volume":"4","author":"Sotgia","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1038\/labinvest.2009.23_bib33","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1074\/jbc.M110970200","article-title":"Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities","volume":"277","author":"Razani","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib34","doi-asserted-by":"crossref","first-page":"C222","DOI":"10.1152\/ajpcell.00006.2003","article-title":"Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue","volume":"285","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2009.23_bib35","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice","volume":"293","author":"Drab","year":"2001","journal-title":"Science"},{"key":"10.1038\/labinvest.2009.23_bib36","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.M105408200","article-title":"Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities","volume":"276","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib37","doi-asserted-by":"crossref","first-page":"11375","DOI":"10.1073\/pnas.172360799","article-title":"Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cardiores.2004.05.018","article-title":"Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression","volume":"63","author":"Jasmin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2009.23_bib39","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00380.2002","article-title":"Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42\/44 MAP kinase in cardiac fibroblasts","volume":"284","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2009.23_bib40","doi-asserted-by":"crossref","first-page":"44H","DOI":"10.1016\/S0002-9149(99)00257-X","article-title":"Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin\u2013angiotensin system","volume":"83","author":"Booz","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1038\/labinvest.2009.23_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1038\/labinvest.2009.23_bib42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.RES.69.6.1557","article-title":"Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts","volume":"69","author":"Kohler","year":"1991","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2009.23_bib43","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1021\/bi049609t","article-title":"Caveolin-1 deficiency stimulates neointima formation during vascular injury","volume":"43","author":"Hassan","year":"2004","journal-title":"Biochemistry"},{"key":"10.1038\/labinvest.2009.23_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.ATV.0000101182.89118.E5","article-title":"Genetic ablation of caveolin-1 confers protection against atherosclerosis","volume":"24","author":"Frank","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/labinvest.2009.23_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.RES.0000136344.27825.72","article-title":"Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis","volume":"95","author":"Sonveaux","year":"2004","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2009.23_bib46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.RES.0000260180.42709.29","article-title":"Caveolin-1 deficiency increases cerebral ischemic injury","volume":"100","author":"Jasmin","year":"2007","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2009.23_bib47","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1096\/fj.06-7719com","article-title":"Mechanisms of cardiac protection from ischemia\/reperfusion injury: a role for caveolae and caveolin-1","volume":"21","author":"Patel","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2009.23_bib48","doi-asserted-by":"crossref","first-page":"25718","DOI":"10.1074\/jbc.274.36.25718","article-title":"Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex","volume":"274","author":"Parolini","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib49","doi-asserted-by":"crossref","first-page":"25708","DOI":"10.1074\/jbc.274.36.25708","article-title":"Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1","volume":"274","author":"Mora","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib50","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1128\/MCB.22.7.2329-2344.2002","article-title":"Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae","volume":"22","author":"Razani","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1038\/labinvest.2009.23_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2353\/ajpath.2007.060687","article-title":"Caveolin-1(\u2212\/\u2212)- and caveolin-2(\u2212\/\u2212)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation","volume":"170","author":"Schubert","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib52","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/hmg\/9.20.3047","article-title":"Caveolin-3 deficiency causes muscle degeneration in mice","volume":"9","author":"Hagiwara","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2009.23_bib53","first-page":"19","article-title":"Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin\u2013glycoprotein complex, and T- tubule abnormalities","volume":"19","author":"Galbiati","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib54","doi-asserted-by":"crossref","first-page":"38988","DOI":"10.1074\/jbc.M205511200","article-title":"Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42\/44 MAPK cascade","volume":"277","author":"Woodman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib55","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/hmg\/ddg313","article-title":"Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype","volume":"12","author":"Aravamudan","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2009.23_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/hmg\/ddh014","article-title":"Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity","volume":"13","author":"Ohsawa","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2009.23_bib57","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0402053101","article-title":"Insulin resistance in skeletal muscles of caveolin-3-null mice","volume":"101","author":"Oshikawa","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2009.23_bib58","doi-asserted-by":"crossref","first-page":"C1317","DOI":"10.1152\/ajpcell.00489.2004","article-title":"Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle","volume":"288","author":"Capozza","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2009.23_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng0498-365","article-title":"Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy","volume":"18","author":"Minetti","year":"1998","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2009.23_bib60","doi-asserted-by":"crossref","first-page":"25632","DOI":"10.1074\/jbc.274.36.25632","article-title":"Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex","volume":"274","author":"Galbiati","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2009.23_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","article-title":"Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy","volume":"313","author":"Hayashi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.2009.23_bib62","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","article-title":"Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome","volume":"114","author":"Vatta","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2009.23_bib63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hrthm.2006.11.030","article-title":"Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3","volume":"4","author":"Cronk","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1038\/labinvest.2009.23_bib64","first-page":"2361","article-title":"Invasion activating caveolin-1 mutation in human scirrhous breast cancers","volume":"61","author":"Hayashi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2009.23_bib65","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2353\/ajpath.2006.051089","article-title":"Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status","volume":"168","author":"Li","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib66","first-page":"435","article-title":"Mutation and aberrant expression of caveolin-1 in human oral squamous cell carcinomas and oral cancer cell lines","volume":"24","author":"Han","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1038\/labinvest.2009.23_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli\u2013Seip congenital lipodystrophy","volume":"93","author":"Ae Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2009.23_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipid Health Dis"},{"key":"10.1038\/labinvest.2009.23_bib69","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/jc.2008-0426","article-title":"Caveolin-1: a new locus for human lipodystrophy","volume":"93","author":"Garg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2009.23_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(03)00168-5","article-title":"Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice","volume":"4","author":"Gratton","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1038\/labinvest.2009.23_bib71","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1158\/0008-5472.CAN-06-4082","article-title":"Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2009.23_bib72","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.106.634709","article-title":"Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"114","author":"Jasmin","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2009.23_bib73","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/82176","article-title":"In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation","volume":"6","author":"Bucci","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2009.23_bib74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/labinvest.2009.23_bib75","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4161\/cbt.7.8.6220","article-title":"Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy","volume":"7","author":"Mercier","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/labinvest.2009.23_bib76","doi-asserted-by":"crossref","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers","author":"Witkiewicz","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib77","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2353\/ajpath.2009.080658","article-title":"Caveolin-1(\u2212\/\u2212) null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts","volume":"174","author":"Sotgia","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.23_bib78","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2353\/ajpath.2009.080882","article-title":"Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions","volume":"174","author":"Mercier","year":"2009","journal-title":"Am J Pathol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest200923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest200923","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722029981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722029981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest200923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:54:00Z","timestamp":1758398040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722029981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0023683722029981"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2009.23","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2009.23","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}